Safety Evaluation of Recombinant Human Interleukin-4
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Interleukin-4: a prototypic immunoregulatory lymphokine
1991 • 878 citations
Murine interleukin-4 displays potent anti-tumor activity in vivo
1989 • 790 citations
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
1991 • 733 citations
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
1992 • 540 citations
Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.
1992 • 89 citations
Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial
1992 • 68 citations
Phase II Studies of Recombinant Human Interleukin-4 in Advanced Renal Cancer and Malignant Melanoma
1994 • 67 citations
A phase II study of subcutaneous recombinant human lnterleukjn-4 in metastatic renal cell carcinoma
1995 • 35 citations
Growth inhibition of human colorectal‐carcinoma cells by interleukin‐4 and expression of functional interleukin‐4 receptors
1994 • 35 citations
Safety Evaluation of Recombinant Human Interleukin-4
1997 • 33 citations
Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model
1995 • 30 citations
Possible Myocardial Toxicity Associated with Interleukin-4 Therapy
1993 • 28 citations
The eosinophil-mediated antitumor activity of interleukin-4
1994 • 27 citations
AN ADENOVIRAL VECTOR EXPRESSING INTERLEUKIN-4 MODULATES TUMORIGENICITY AND INDUCES REGRESSION IN A MURINE BREAST-CANCER MODEL
1995 • 27 citations
IL4 and IL5: The role of two multifunctional cytokines and their place in the network of cytokine interactions
1990 • 15 citations
Intralesional Treatment of Established Murine Primary Renal Tumor With Interleukin-4: Localized Effect on Primary Tumor With no Impact on Metastases
1995 • 11 citations
Recombinant human interleukin 4 (IL-4) sch 39400 in non-small cell lung cancer (NSCLC): Results of a phase II investigation
1994 • 8 citations
Cited By (0)
No citing papers found in database